| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/20/1992 | EP0486386A2 Novel derivatives of N-benzoylproline, process for their preparation and drugs containing them |
| 05/20/1992 | EP0486385A1 Imidazole derivatives, process for their fabrication and pharmaceutical compositions containing them |
| 05/20/1992 | EP0486353A1 Anhydrous composition containing lactulose |
| 05/20/1992 | EP0486280A2 Piperidinylcamphorsulfonyl oxytocin antagonists |
| 05/20/1992 | EP0486271A2 Cholecystokinin antagonists for treating neurological disorders |
| 05/20/1992 | EP0486211A1 Isoquinoline derivatives |
| 05/20/1992 | EP0486153A2 Enzymatic hydrolysis of lovastatin acid using an enzyme derived from Clonostachys compactiuscula |
| 05/20/1992 | EP0486118A1 Method for detecting cobalamin and folic acid deficiency |
| 05/20/1992 | EP0486046A2 S(+)-Phenyl-alkanoic acids and aminosugar containing complexes |
| 05/20/1992 | EP0486045A2 S(+)-Phenyl-alkanoic acids and alpha-amino acid containing complexes |
| 05/20/1992 | EP0486022A2 Naphthalene derivatives |
| 05/20/1992 | EP0485984A2 Diarylmethoxypiperidine derivatives |
| 05/20/1992 | EP0485962A2 New tricyclic compounds |
| 05/20/1992 | EP0485929A1 Substituted azoles, process for their preparation and their application |
| 05/20/1992 | EP0485894A1 Semi-synthetic diastereomerically pure N-glycidyl-anthracyclines, methods for their preparation, and their use as cytostatics |
| 05/20/1992 | EP0485890A2 Use of 2,3-disubstituate 1-azolyl-propane for inhibiting the pathogenic growth phase of dimorph yeast cell |
| 05/20/1992 | EP0485808A2 Antibiotic C-3 catechol-substituted cephalosporin compounds, compositions and use thereof |
| 05/20/1992 | EP0485748A2 Salts of glycosaminoglycans with esters of aminoacids, preparation thereof and pharmaceutical formulations containing them |
| 05/20/1992 | EP0485725A1 Alpha-glucosidase inhibitor, pradimicin Q |
| 05/20/1992 | EP0485530A1 TGF-$g(b) PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION |
| 05/20/1992 | EP0485512A1 Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine antagonists. |
| 05/20/1992 | EP0485486A1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby. |
| 05/20/1992 | EP0485434A1 Shelf stable aspirin solutions |
| 05/20/1992 | EP0485392A1 Androgen derivatives for use in the inhibition of sex steroid activity |
| 05/20/1992 | EP0485381A1 Use of macrolactones as anti-allergy agents. |
| 05/20/1992 | EP0428707A4 Steroid modified oligonucleotides |
| 05/20/1992 | EP0347448B1 Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases |
| 05/20/1992 | EP0346419B1 Amino-4 trifluoromethyl-1 tetraline derivatives, their preparation and therapeutic application |
| 05/20/1992 | EP0287646B1 Cosmetic preparations containing ubidecarenones |
| 05/20/1992 | EP0248057B1 Glucose tolerance factor and method of making same |
| 05/20/1992 | EP0225367B1 Film forming composition for topical use |
| 05/20/1992 | CN1061225A Epiodophylltoxin glucoside 4'-phosphate |
| 05/20/1992 | CN1061224A Indole-and benzimidazole-substitued imidazole and benzimidazole derivatives |
| 05/20/1992 | CN1061220A 1alpha-hydroxy vitamin d4 and intermediates and analogues |
| 05/20/1992 | CN1061218A Tri-lower alkoxy benzene derivatives |
| 05/20/1992 | CN1061155A Preparation method of injection embolism medicament for birth control with reducibility |
| 05/20/1992 | CN1061154A Preparation method of concentrated protoplasm for micro-elements |
| 05/20/1992 | CN1061153A Pharmaceutical composition and process for preparation of it |
| 05/20/1992 | CN1061152A Ester inhibitors |
| 05/20/1992 | CN1016692B Method for preparation of trycyclic pyridazopyridone derivatives |
| 05/20/1992 | CN1016691B Process for preparation of antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl) phridines |
| 05/20/1992 | CN1016689B Method for preparation of 2,3-thiomorpholine diketone-2-oxime derivative |
| 05/20/1992 | CN1016687B Process for preparation of alpha-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-y1) benzene-acetonitriles |
| 05/20/1992 | CN1016668B Method for preparation of medicines composition for treating arteriosclerosis |
| 05/20/1992 | CN1016663B Pig feed |
| 05/20/1992 | CA2055685A1 Hiv protease inhibitors having polyether substituents |
| 05/20/1992 | CA2054555A1 Nitrogen compounds |
| 05/19/1992 | US5114978 Cleaning compounds with antimicrobial properties |
| 05/19/1992 | US5114976 Method for treating certain psychiatric disorders and certain psychiatric symptoms |
| 05/19/1992 | US5114974 Treatment of atherosclerosis with MgNa2 EDTA |
| 05/19/1992 | US5114973 Method for treating autoimmune disease using succinylacetone |
| 05/19/1992 | US5114972 Synthesis and uses of new ascorbic acid derivatives which have anti-oxidant and anti-cancer activities |
| 05/19/1992 | US5114971 Esters of prostaglandins |
| 05/19/1992 | US5114969 Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same |
| 05/19/1992 | US5114967 Antibiotic alisamycin and its use |
| 05/19/1992 | US5114966 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)-substituted, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties |
| 05/19/1992 | US5114963 Reducing the risk of atherosclerosis |
| 05/19/1992 | US5114960 Substituted isoxazole derivatives |
| 05/19/1992 | US5114957 Tocopherol-based antiviral agents and method of using same |
| 05/19/1992 | US5114956 Parenteral formulation of nimodipine |
| 05/19/1992 | US5114955 Derivatives with pyridine as gastrointestinal disorders and antisecretory agents |
| 05/19/1992 | US5114954 Methylenedioxybenzene seleno derivatives |
| 05/19/1992 | US5114953 Peptides |
| 05/19/1992 | US5114952 Isoquinolinylsulfonamides as anti-arrhythmic agents |
| 05/19/1992 | US5114951 Agents for combating multiple drug resistance |
| 05/19/1992 | US5114950 Psychological disorders, anxiety, nausea and vomiting |
| 05/19/1992 | US5114949 Heterocyclic derivatives, their preparation and medicinal products containing them |
| 05/19/1992 | US5114948 Oxidation resistance by adding methionine, cysteine, or cysteine hydrochloride |
| 05/19/1992 | US5114947 Benzofuran-7-carboxamides as anxiolytic agents |
| 05/19/1992 | US5114943 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 05/19/1992 | US5114942 Treating habit disorders |
| 05/19/1992 | US5114941 Pyrimidinedione derivative compounds, method for preparing same, and antiarrythmic agents containing same |
| 05/19/1992 | US5114938 Parasiticidal substituted hexahydro-1,2,4-triazinediones and use thereas |
| 05/19/1992 | US5114936 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use |
| 05/19/1992 | US5114935 Substituted 6-benzyl-2h-3,4,5,6-tetrahydro-(1,3)-oxazines |
| 05/19/1992 | US5114934 Tricyclic pyridone derivatives |
| 05/19/1992 | US5114933 Cephalosporin compounds |
| 05/19/1992 | US5114932 Synthetic blood; oxygen carrier; surgery |
| 05/19/1992 | US5114931 Antilipemic agents, atheriosclerosis or antidepressants |
| 05/19/1992 | US5114930 Anthelmintics |
| 05/19/1992 | US5114929 Oral administration of antibiotics from an unpressurized container |
| 05/19/1992 | US5114927 Hypotensive agents and inhibiting renin |
| 05/19/1992 | US5114848 Prepared from bifidobacterium; immunomodulating properties |
| 05/19/1992 | US5114715 Analgesics to be administered by inhalation |
| 05/19/1992 | US5114714 Methods of use and compositions of (r)-isoflurane and (r)-desflurane |
| 05/19/1992 | US5114709 Ferric ion coordinated polyamine resins for the lowering of blood cholesterol |
| 05/19/1992 | US5114708 Animal growth regulators, administering a polyether copolymer ethylene oxide-propylene oxide modified ethylenediamine |
| 05/19/1992 | CA1301187C Process for the continuous fractionation of a mixture of fatty acids |
| 05/19/1992 | CA1301183C2 Aralykyl (arylethynyl) aralkyl amines and their use as vasodilators and antihypertensives |
| 05/19/1992 | CA1301181C2 Oxiranes |
| 05/19/1992 | CA1301179C 7-oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as "dual inhibitors" |
| 05/19/1992 | CA1301174C Substituted 1h-imidazoles |
| 05/19/1992 | CA1301172C Thianaphthene derivatives, their production and use |
| 05/19/1992 | CA1301171C 1,12b-disubstituted octahydroindolo ¬2,3-a| quinolizine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 05/19/1992 | CA1301170C Benzofuran 7-carboxamides useful as antiemetic or antipsyschotic agents |
| 05/19/1992 | CA1301165C 23-oxo (keto) and 23-imino derivatives of mono- and diepoxy ll-f28249 compounds |
| 05/19/1992 | CA1301164C 23-oxo (keto) and 23-imino derivatives of ll-f28249 compounds |
| 05/19/1992 | CA1301162C New 11-arylsteroid compounds |
| 05/19/1992 | CA1301156C 4(3h)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives |
| 05/19/1992 | CA1301155C Diastereoisomeric tetrahydropyrido (2,3,-d)pyrimidine derivatives |